TRVI Trevi Therapeutics, Inc. - Common Stock
NASDAQ · Pharmaceuticals · SEC EDGAR'da Görüntüle ↗ kapat Eki 2, 2026 10-K/10-Q Ağu 6, 2026
$13,91
· 52 haftalık aralığın %'i
· düşüğün üstünde
· yükseğe
$9,2852 haftanın en düşüğü
$20,2252 haftanın en yükseği
Piyasa Değeri (MRQ)
$1.98B
P/E
-43.5
Hisse Başına Kâr
$-0.32
rozetleriniz
52 Haftlık Aralık
$9–$20
Analist Derecelendirmesi
BUY
Fiyat Hedefi
$28
P/E
-43.5
ROE
-22.4%
Net Kâr Marjı
·
Rozet şeridiniz boş — bu sayfada herhangi bir metriği sabitleyin.
TRVI Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$13.91
Piyasa Değeri (MRQ)
$1.98B
P/E
-43.5
Hisse Başına Kâr
$-0.32
ROE
-22.4%
52 Haftlık Aralık
$9–$20
TRVI Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
aralık
çubuklar
Çubuk çözünürlüğü seçilen döneme uyum sağlar — bir çubuk için açılış/yüksek/düşük/kapanış değerlerini görmek için grafiğin üzerine gelin.
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Hisse Başına Kâr$-0.322021-12-31 → 2025-12-31
Serbest Nakit Akışı$-42M2019-12-31 → 2025-12-31
Değerleme ve Oranlar
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
| Metrik | 5 Yıllık trend | TRVI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| P/E | -43.55Y ort. ≈-11.5 | ≈-11.5 | · | · | |
| F/D (MRQ) | 6.25Y ort. ≈3.2 | ≈3.2 | 4.0 | Aşırı değerli | |
| Fiyat / Serbest Nakit Akışı (TTM) | -37.55Y ort. ≈-13.8 | ≈-13.8 | · | · | |
| Fiyat / Nakit Akışı (TTM) | -37.65Y ort. ≈-11.2 | ≈-11.2 | · | · | |
| Price / Tangible Book (Fiyat / Maddi Defter Değeri) | 9.75Y ort. ≈3.2 | ≈3.2 | · | · |
Akran ortalaması, metrik başına standartlaştırılmış bir temelde hesaplanır ve bu hisse senedi için gösterilen TTM/MRQ temelini her zaman eşleşmeyebilir.
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
| Metrik | 5 Yıllık trend | TRVI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| ROA | -28.1%5Y ort. ≈-43.7% | ≈-43.7% | -6.8% | Zayıf | |
| ROE | -22.4%5Y ort. ≈-76.4% | ≈-76.4% | -11.4% | Zayıf | |
| ROIC | -26.9%5Y ort. ≈-67.5% | ≈-67.5% | -16.0% | Zayıf |
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
| Metrik | 5 Yıllık trend | TRVI | 5Y ort. | Akran Ortalaması | Sonuç |
|---|---|---|---|---|---|
| Cari Oran (MRQ) | 37.35Y ort. ≈11.4 | ≈11.4 | 5.5 | Güçlü likidite | |
| Quick Ratio (Cari Oran) | 19.35Y ort. ≈11.1 | ≈11.1 | 4.2 | Güçlü likidite |
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Bu oran grubu için henüz veri yok
Bu oran grubunu hesaplamak için henüz yeterli temel veriye sahip değil.
değer · ≈ 5Y ort. · sektör ortalaması · ortalamaya göre değerlendirme
Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
Ort. Sürpriz
13.7%
Sonraki Rapor
Kas 11, 2026
| Dönem | Rapor | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|---|
| 30 Haziran 2026 | Ağu 5, 2026 | $-0.11 | $-0.11 | 2.2% |
| 31 Mart 2026 | $-0.09 | $-0.08 | -15.4% | |
| 31 Aralık 2025 | $-0.06 | $-0.10 | 40.1% | |
| 30 Eylül 2025 | $-0.08 | $-0.10 | 20.2% | |
| 30 Haziran 2025 | $-0.09 | $-0.10 | 12.6% | |
| 31 Mart 2025 | $-0.09 | $-0.12 | 27.1% | |
| 31 Aralık 2024 | $-0.11 | $-0.12 | 9.3% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $33M | $39M | $24M | $20M | $23M | $22M | $19M | $14M | |
| SG&A Expense | $16M | $12M | $10M | $10M | $9M | $10M | $7M | $4M | |
| Operating Expenses | $49M | $52M | $34M | $30M | $32M | $32M | $27M | $18M | |
| Operating Income | $-49M | $-52M | $-34M | $-30M | $-32M | $-32M | $-27M | $-18M | |
| Interest Expense | · | · | $391.0K | $1M | $1M | $456.0K | · | $174.0K | |
| Interest Income | $7M | $4M | $5M | · | · | · | · | · | |
| Other Non-op | $-31.0K | $-15.0K | $469.0K | $289.0K | $-375.0K | $-287.0K | $577.0K | $-2M | |
| Pretax Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| Income Tax | $-64.0K | $-30.0K | $-32.0K | $-36.0K | $-21.0K | $-18.0K | $-18.0K | $-124.0K | |
| Net Income | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | $-21M | |
| EPS (Basic) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| EPS (Diluted) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · | |
| Shares (Basic) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| Shares (Diluted) | 134,747,198 | 101,971,873 | 99,033,373 | 64,541,911 | 22,841,481 | · | · | · | |
| EBITDA | $-49M | $-51M | $-34M | $-30M | $-32M | $-32M | $-27M | · |
Bilanço
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $34M | $32M | $13M | $37M | $45M | $57M | $7M | |
| Short-term Investments | $169M | $74M | $51M | $108M | · | · | · | · | |
| Prepaid Expense | $1M | $939.0K | $4M | $795.0K | $886.0K | $1M | $2M | $1M | |
| Other Current Assets | $2M | $867.0K | $955.0K | $1M | $241.0K | $265.0K | · | · | |
| Current Assets | $192M | $109M | $88M | $123M | $38M | $46M | $60M | $9M | |
| PP&E (Net) | $178.0K | $157.0K | $216.0K | $170.0K | $53.0K | $103.0K | $118.0K | $149.0K | |
| PP&E (Gross) | $537.0K | $385.0K | $350.0K | $395.0K | $235.0K | $235.0K | $203.0K | $195.0K | |
| Accum. Depreciation | $359.0K | $228.0K | $134.0K | $225.0K | $182.0K | $132.0K | $85.0K | $46.0K | |
| Other Non-current Assets | $928.0K | $243.0K | $297.0K | $205.0K | $334.0K | $532.0K | · | · | |
| Total Assets | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Accounts Payable | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $603.0K | |
| Accrued Liabilities | $6M | $7M | $4M | $4M | $4M | $3M | $4M | $2M | |
| Current Liabilities | $10M | $11M | $6M | $13M | $13M | $6M | $5M | $3M | |
| Capital Leases | $446.0K | $747.0K | $1M | $2.0K | $24.0K | $144.0K | $257.0K | $46.0K | |
| Other Non-current Liabilities | · | · | · | $3.0K | · | · | · | · | |
| Total Liabilities | $10M | $11M | $7M | $16M | $21M | $20M | · | · | |
| Common Stock | $128.0K | $94.0K | $68.0K | $60.0K | $29.0K | $19.0K | $18.0K | $4.0K | |
| Paid-in Capital | $513M | $387M | $322M | $318M | $198M | $174M | $169M | · | |
| Retained Earnings | $-330M | $-287M | $-239M | $-210M | $-181M | $-147M | $-114M | $-109M | |
| AOCI | $148.0K | $61.0K | $-29.0K | $-122.0K | · | · | · | · | |
| Stockholders' Equity | $183M | $100M | $83M | $107M | $17M | $27M | $55M | $-109M | |
| Liabilities + Equity | $193M | $111M | $89M | $123M | $38M | $47M | $60M | $11M | |
| Shares Outstanding | 128,306,056 | 93,602,631 | 68,283,699 | 59,943,430 | 28,505,804 | 18,546,786 | 17,834,570 | 438,600 |
Nakit Akışı
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| D&A | $144.0K | $147.0K | $123.0K | $43.0K | · | · | · | · | |
| Stock-based Comp | $5M | $4M | $2M | $2M | $3M | $2M | $1M | $496.0K | |
| Other Non-cash | $-5M | $6M | $-5M | · | · | · | · | · | |
| Operating Cash Flow | $-42M | $-38M | $-32M | $-28M | $-29M | $-29M | $-23M | $-18M | |
| CapEx | $12.0K | $35.0K | $137.0K | $159.0K | · | $32.0K | $9.0K | $158.0K | |
| Investing Cash Flow | $-94M | $-22M | $59M | $-107M | · | $-32.0K | $-9.0K | $-158.0K | |
| Debt Issued | · | · | · | · | · | $14M | · | · | |
| Net Debt Issued | · | · | · | $-6M | · | $14M | · | · | |
| Financing Cash Flow | $121M | $61M | $-8M | $111M | $21M | $17M | $73M | $4M | |
| Net Change in Cash | $-15M | $2M | $20M | $-24M | $-8M | $-12M | $50M | $-15M | |
| Taxes Paid | $-33.0K | $-32.0K | · | · | · | · | · | · | |
| Free Cash Flow | $-42M | $-38M | $-32M | $-28M | · | $-29M | $-23M | · | |
| Levered FCF | · | · | $-32M | $-29M | · | $-29M | · | · |
Kârlılık
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| ROA | -28.1% | -47.8% | -27.4% | -36.1% | -79.3% | -61.2% | -73.9% | · | |
| ROE | -22.4% | -60.4% | -33.8% | -26.8% | -238.5% | -104.2% | -45.2% | · | |
| ROIC | -26.9% | -51.7% | -41.0% | -27.8% | -190.1% | -119.0% | -48.8% | · |
Likidite ve Solventlik
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 | 8.3 | 11.5 | · | |
| Quick Ratio | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 | 8.1 | 11.0 | · | |
| Interest Coverage | · | · | -86.8 | -25.7 | -27.0 | -71.2 | · | · |
Hisse Başına
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.43 | $1.06 | $1.21 | $1.79 | $0.60 | $1.47 | $3.06 | · | |
| Cash Flow / Share | $-0.31 | $-0.38 | $-0.32 | $-0.44 | · | · | · | · | |
| Cash / Share | $0.15 | $0.36 | $0.47 | $0.21 | $1.29 | $2.43 | $3.21 | · | |
| EPS (TTM) | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 | · | · | · |
Değerleme (TTM)
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-43M | $-48M | $-29M | $-29M | $-34M | $-33M | $-26M | · | |
| Market Cap | $1.61B | $386M | $92M | $116M | $22M | $45M | $67M | · | |
| P/E | -39.1 | -8.8 | -4.6 | -4.3 | -0.5 | · | · | · | |
| P/B | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | 1.2 | · | |
| P / Tangible Book | 8.8 | 3.9 | 1.1 | 1.1 | 1.3 | 1.6 | · | · | |
| P / Cash Flow | -38.2 | -10.1 | -2.9 | -4.1 | -0.8 | -1.5 | -2.9 | · | |
| P / FCF | -38.2 | -10.1 | -2.9 | -4.1 | · | -1.5 | -2.9 | · | |
| Earnings Yield | -2.6% | -11.4% | -21.6% | -23.3% | -190.5% | · | · | · |
Gelir Tablosu
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $10M | $6M | $10M | $9M | $8M | $9M | $11M | $10M | $9M | $7M | $6M | $6M | $5M | $4M | $6M | |
| SG&A Expense | $5M | $5M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | |
| Operating Expenses | $21M | $15M | $10M | $14M | $14M | $11M | $12M | $14M | $13M | $12M | $9M | $9M | $8M | $8M | $7M | $8M | |
| Operating Income | $-21M | $-15M | $-10M | $-14M | $-14M | $-11M | $-12M | $-14M | $-13M | $-12M | $-9M | $-9M | $-8M | $-8M | $-7M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | $1.0K | $1.0K | · | $3.0K | $153.0K | $231.0K | $274.0K | $292.0K | |
| Interest Income | $3M | $2M | $2M | $2M | $1M | $1M | $843.0K | $826.0K | $935.0K | $998.0K | $1M | $1M | · | · | · | · | |
| Other Non-op | $-3.0K | $4.0K | $-16.0K | $-2.0K | $-7.0K | $-6.0K | $2.0K | $-11.0K | $-5.0K | $-1.0K | $-3.0K | $154.0K | $153.0K | $165.0K | $702.0K | $132.0K | |
| Pretax Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| Income Tax | $-19.0K | $-20.0K | $-17.0K | $-15.0K | $-21.0K | $-11.0K | $17.0K | $-31.0K | $-8.0K | $-8.0K | $18.0K | $-13.0K | $-30.0K | $-7.0K | $-20.0K | $-7.0K | |
| Net Income | $-18M | $-13M | $-8M | $-12M | $-12M | $-10M | $-11M | $-13M | $-12M | $-11M | $-8M | $-8M | $-7M | $-6M | $-6M | $-8M | |
| EPS (Basic) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| EPS (Diluted) | $-0.11 | $-0.09 | $-0.06 | $-0.08 | $-0.09 | $-0.09 | $-0.11 | $-0.13 | $-0.12 | $-0.11 | $-0.08 | $-0.08 | $-0.07 | $-0.06 | $0.05 | $-0.12 | |
| Shares (Basic) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| Shares (Diluted) | 156,602,158 | 145,592,901 | · | 145,104,986 | 130,350,391 | 117,610,750 | · | 101,282,228 | 101,041,573 | 99,517,212 | · | 99,325,540 | 98,698,579 | 98,610,671 | · | 68,898,810 | |
| EBITDA | $-21M | $-15M | · | $-14M | $-14M | $-11M | · | $-14M | $-13M | $-12M | · | $-9M | $-8M | $-8M | · | $-8M |
Bilanço
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $54M | $19M | $19M | $57M | $117M | $19M | $34M | $16M | $13M | $14M | $32M | $26M | $14M | $12M | $13M | $67M | |
| Short-term Investments | $265M | $152M | $169M | $138M | $87M | $84M | $74M | $49M | $57M | $59M | $51M | $63M | $80M | $100M | $108M | $59M | |
| Prepaid Expense | $4M | $2M | $1M | $1M | $2M | $2M | $939.0K | $1M | $2M | $3M | $4M | $4M | $3M | $1M | $795.0K | $1M | |
| Other Current Assets | $3M | $2M | $2M | $2M | $2M | $834.0K | $867.0K | $667.0K | $830.0K | $721.0K | $955.0K | $1M | $2M | $2M | $1M | $421.0K | |
| Current Assets | $326M | $176M | $192M | $198M | $207M | $106M | $109M | $67M | $72M | $77M | $88M | $94M | $99M | $114M | $123M | $127M | |
| PP&E (Net) | $336.0K | $265.0K | $178.0K | $213.0K | $239.0K | $277.0K | $157.0K | $174.0K | $198.0K | $204.0K | $216.0K | $238.0K | $225.0K | $245.0K | $170.0K | $68.0K | |
| PP&E (Gross) | · | · | $537.0K | · | · | · | $385.0K | · | · | · | $350.0K | · | · | · | $395.0K | · | |
| Accum. Depreciation | · | · | $359.0K | · | · | · | $228.0K | · | · | · | $134.0K | · | · | · | $225.0K | · | |
| Other Non-current Assets | $4M | $3M | $928.0K | $103.0K | $68.0K | $241.0K | $243.0K | $256.0K | $273.0K | $311.0K | $297.0K | $297.0K | $68.0K | $225.0K | $205.0K | $922.0K | |
| Total Assets | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Accounts Payable | $3M | $2M | $4M | $3M | $3M | $1M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $3M | $2M | |
| Accrued Liabilities | $5M | $5M | $6M | $6M | $6M | $5M | $7M | $7M | $5M | $3M | $4M | $4M | $3M | $3M | $4M | $5M | |
| Current Liabilities | $9M | $7M | $10M | $9M | $9M | $7M | $11M | $9M | $7M | $5M | $6M | $5M | $5M | $13M | $13M | $15M | |
| Capital Leases | $276.0K | $364.0K | $446.0K | $527.0K | $605.0K | $681.0K | $747.0K | $816.0K | $884.0K | $949.0K | $1M | $1M | $1M | $1M | $2.0K | $2.0K | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $3.0K | $15.0K | |
| Total Liabilities | $9M | $7M | $10M | $10M | $10M | $8M | $11M | $10M | $8M | $6M | $7M | $6M | $6M | $14M | $16M | $18M | |
| Common Stock | $142.0K | $128.0K | $128.0K | $128.0K | $122.0K | $100.0K | $94.0K | $75.0K | $73.0K | $69.0K | $68.0K | $64.0K | $63.0K | $60.0K | $60.0K | $58.0K | |
| Paid-in Capital | $683M | $515M | $513M | $511M | $508M | $397M | $387M | $334M | $329M | $322M | $322M | $321M | $319M | $318M | $318M | $315M | |
| Retained Earnings | $-361M | $-343M | $-330M | $-321M | $-310M | $-297M | $-287M | $-276M | $-262M | $-250M | $-239M | $-231M | $-224M | $-216M | $-210M | $-205M | |
| AOCI | $-425.0K | $-190.0K | $148.0K | $30.0K | $24.0K | $73.0K | $61.0K | $139.0K | $-84.0K | $-67.0K | $-29.0K | $-217.0K | $-248.0K | $-88.0K | $-122.0K | $-263.0K | |
| Stockholders' Equity | $322M | $172M | $183M | $190M | $198M | $99M | $100M | $59M | $66M | $72M | $83M | $90M | $95M | $102M | $107M | $110M | |
| Liabilities + Equity | $331M | $180M | $193M | $199M | $208M | $107M | $111M | $69M | $74M | $79M | $89M | $96M | $101M | $116M | $123M | $128M | |
| Shares Outstanding | 142,420,883 | 128,411,048 | 128,306,056 | 128,215,113 | 121,775,753 | 99,892,915 | 93,602,631 | 75,454,375 | 72,591,917 | 68,960,167 | 68,283,699 | 63,855,330 | 63,098,455 | 60,065,408 | 59,943,430 | 58,322,517 |
Nakit Akışı
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $34.0K | $34.0K | $31.0K | $38.0K | $38.0K | $37.0K | $38.0K | $36.0K | $38.0K | $35.0K | $35.0K | $35.0K | $34.0K | $19.0K | $15.0K | $9.0K | |
| Stock-based Comp | $3M | $2M | $1M | $1M | $1M | $1M | $916.0K | $822.0K | $1M | $723.0K | $609.0K | $530.0K | $530.0K | $578.0K | $501.0K | $569.0K | |
| Other Non-cash | · | $-6M | · | · | · | $-4M | · | · | · | $-323.0K | · | · | · | $-2M | · | · | |
| Operating Cash Flow | $-17M | $-17M | $-8M | $-11M | $-10M | $-13M | $-10M | $-10M | $-9M | $-10M | $-6M | $-7M | $-10M | $-8M | $-6M | $-9M | |
| CapEx | $124.0K | $102.0K | $0 | $12.0K | · | · | $7.0K | $0 | · | · | $22.0K | $18.0K | $40.0K | $57.0K | $116.0K | · | |
| Investing Cash Flow | $-112M | $17M | $-31M | $-51M | $-3M | $-10M | $-24M | $8M | $3M | $-8M | $13M | $18M | $20M | $9M | $-48M | $-5M | |
| Net Debt Issued | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · | · | |
| Financing Cash Flow | $164M | $222.0K | $284.0K | $2M | $110M | $9M | $51M | $5M | $5M | $-28.0K | $-54.0K | $2M | $-8M | $-2M | $652.0K | $55M | |
| Net Change in Cash | $35M | $498.0K | $-38M | $-60M | $98M | $-15M | $18M | $3M | $-848.0K | $-19M | $6M | $12M | $2M | $-938.0K | $-54M | $42M | |
| Free Cash Flow | · | $-17M | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | · | · | $-8M | · | · |
Kârlılık
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -6.6% | -9.2% | · | -8.8% | -8.7% | -11.1% | · | -16.1% | -14.1% | -11.2% | · | -6.9% | -7.8% | -8.7% | · | -10.3% | |
| ROE | -6.9% | -9.7% | · | -9.5% | -9.3% | -12.0% | · | -17.8% | -15.3% | -12.5% | · | -7.7% | -9.2% | -11.4% | · | -13.6% | |
| ROIC | -6.4% | -8.6% | · | -7.3% | -6.9% | -11.5% | · | -23.8% | -20.1% | -16.4% | · | -10.1% | -8.8% | -7.4% | · | -7.6% |
Likidite ve Solventlik
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 37.3 | 24.8 | · | 21.9 | 22.4 | 15.4 | · | 7.4 | 10.7 | 14.6 | · | 18.2 | 21.1 | 8.7 | · | 8.7 | |
| Quick Ratio | 36.5 | 24.1 | · | 21.6 | 22.1 | 15.0 | · | 7.2 | 10.3 | 13.8 | · | 17.2 | 20.0 | 8.4 | · | 8.6 | |
| Interest Coverage | · | · | · | · | · | · | · | · | -13289.0 | -11906.0 | · | -3015.0 | -54.8 | -32.7 | · | -28.8 |
Hisse Başına
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $2.26 | $1.34 | · | $1.48 | $1.63 | $1.00 | · | $0.78 | $0.91 | $1.05 | · | $1.40 | $1.51 | $1.69 | · | $1.88 | |
| Cash Flow / Share | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.11 | · | · | · | $-0.08 | · | · | |
| Cash / Share | $0.38 | $0.15 | · | $0.44 | $0.96 | $0.19 | · | $0.21 | $0.18 | $0.20 | · | $0.41 | $0.22 | $0.19 | · | $1.14 | |
| EPS (TTM) | $-0.34 | $-0.32 | · | $-0.37 | $-0.42 | $-0.45 | · | $-0.44 | $-0.39 | $-0.34 | · | $-0.16 | $-0.20 | $-0.27 | · | $-0.74 |
Değerleme (TTM)
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-51M | $-46M | · | $-46M | $-47M | $-47M | · | $-44M | $-39M | $-34M | · | $-27M | $-27M | $-28M | · | $-32M | |
| Market Cap | $2.66B | $1.53B | · | $1.17B | $666M | $628M | · | $252M | $216M | $238M | · | $139M | $151M | $111M | · | $90M | |
| P/E | -54.9 | -37.3 | · | -24.7 | -13.0 | -14.0 | · | -7.6 | -7.6 | -10.1 | · | -13.6 | -11.9 | -6.9 | · | -2.1 | |
| P/B | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Tangible Book | 8.3 | 8.9 | · | 6.2 | 3.4 | 6.3 | · | 4.3 | 3.3 | 3.3 | · | 1.6 | 1.6 | 1.1 | · | 0.8 | |
| P / Cash Flow | · | -91.8 | · | · | · | -46.6 | · | · | · | -22.7 | · | · | · | -13.6 | · | · | |
| Earnings Yield | -1.8% | -2.7% | · | -4.0% | -7.7% | -7.1% | · | -13.2% | -13.1% | -9.9% | · | -7.3% | -8.4% | -14.6% | · | -48.0% |
En son dönem solda · null değerler · olarak gösterilir
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Gelir | $-43M | $-48M | $-29M | $-29M | $-34M |
| Seyreltilmiş Hisse Başı Kâr | $-0.32 | $-0.47 | $-0.29 | $-0.45 | $-1.49 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Cari Oran | 19.7 | 10.4 | 15.0 | 9.2 | 3.0 |
| Cari Oran | 19.3 | 10.2 | 14.2 | 9.0 | 2.9 |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-42M | $-38M | $-32M | $-28M | · |
Kurumsal Sahipler (13F) 226 dosya · $2.8B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Sahipler
226
Tutulan Değer
$2.8B
Yeni pozisyonlar
41
Çıkan pozisyonlar
19
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 41 (-2 önceki Ç'ye göre) | 19 (-5 önceki Ç'ye göre) | 89 (+23 önceki Ç'ye göre) | 61 (-4 önceki Ç'ye göre) | +13.7M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| NEA Management Company, LLC | $246.594.552 | 13.222.228 | 8,67% | Hisse senetleri |
| FMR LLC | $234.296.949 | 12.562.839 | 8,24% | Hisse senetleri |
| BlackRock, Inc. | $208.041.234 | 11.155.026 | 7,32% | Hisse senetleri |
| Frazier Life Sciences Management, L.P. | $185.370.687 | 9.939.447 | 6,52% | Hisse senetleri |
| WELLINGTON MANAGEMENT GROUP LLP | $106.017.642 | 5.684.592 | 3,73% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $103.147.089 | 5.530.675 | 3,63% | Hisse senetleri |
| Vivo Capital, LLC | $95.015.558 | 5.094.668 | 3,34% | Hisse senetleri |
| VANGUARD GROUP INC | $80.561.880 | 6.434.655 | 2,83% | Hisse senetleri |
| Woodline Partners LP | $76.116.860 | 4.081.333 | 2,68% | Hisse senetleri |
| Vestal Point Capital, LP | $57.815.000 | 3.100.000 | 2,03% | Hisse senetleri |
| MPM BIOIMPACT LLC | $57.322.211 | 3.073.577 | 2,02% | Hisse senetleri |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $57.269.301 | 3.070.740 | 2,01% | Hisse senetleri |
| STATE STREET CORP | $56.459.425 | 3.027.315 | 1,99% | Hisse senetleri |
| GEODE CAPITAL MANAGEMENT, LLC | $54.619.528 | 2.928.068 | 1,92% | Hisse senetleri |
| MARSHALL WACE, LLP | $49.872.655 | 2.674.137 | 1,75% | Hisse senetleri |
| EVENTIDE ASSET MANAGEMENT, LLC | $49.609.000 | 2.660.000 | 1,74% | Hisse senetleri |
| Rubric Capital Management LP | $46.709.167 | 2.504.513 | 1,64% | Hisse senetleri |
| Artia Global Partners LP | $41.232.390 | 2.210.852 | 1,45% | Hisse senetleri |
| ACORN CAPITAL ADVISORS, LLC | $40.001.341 | 2.144.844 | 1,41% | Hisse senetleri |
| First Light Asset Management, LLC | $39.113.060 | 2.097.215 | 1,38% | Hisse senetleri |
| Pictet Asset Management Holding SA | $37.557.109 | 2.013.786 | 1,32% | Hisse senetleri |
| Logos Global Management LP | $35.062.000 | 1.880.000 | 1,23% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $33.573.208 | 1.800.172 | 1,18% | Hisse senetleri |
| EMERALD ADVISERS, LLC | $33.525.445 | 1.797.611 | 1,18% | Hisse senetleri |
| Siren, L.L.C. | $33.325.070 | 1.786.867 | 1,17% | Hisse senetleri |
| Pivotal bioVenture Partners Investment Advisor LLC | $32.500.833 | 1.742.672 | 1,14% | Hisse senetleri |
| RAYMOND JAMES FINANCIAL INC | $30.038.753 | 1.610.657 | 1,06% | Hisse senetleri |
| VIKING GLOBAL INVESTORS LP | $28.807.611 | 1.544.644 | 1,01% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $28.588.381 | 1.532.889 | 1,01% | Hisse senetleri |
| Assenagon Asset Management S.A. | $28.447.106 | 1.525.314 | 1,00% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $28.100.554 | 2.355.453 | 0,99% | Hisse senetleri |
| ORBIMED ADVISORS LLC | $26.674.964 | 1.430.293 | 0,94% | Hisse senetleri |
| Jones Hill Capital LP | $24.976.304 | 1.339.212 | 0,88% | Hisse senetleri |
| NAN FUNG TRINITY (HK) LTD | $22.634.013 | 1.213.620 | 0,80% | Hisse senetleri |
| EMERALD MUTUAL FUND ADVISERS TRUST | $22.584.497 | 1.210.965 | 0,79% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $22.426.998 | 1.202.520 | 0,79% | Hisse senetleri |
| Soleus Capital Management, L.P. | $21.999.876 | 1.179.618 | 0,77% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $21.948.663 | 1.176.872 | 0,77% | Hisse senetleri |
| BARCLAYS PLC | $21.299.737 | 1.142.077 | 0,75% | Hisse senetleri |
| Saturn V Capital Management LP | $19.620.602 | 1.052.043 | 0,69% | Hisse senetleri |
| FLPUTNAM INVESTMENT MANAGEMENT CO | $19.359.763 | 1.038.057 | 0,68% | Hisse senetleri |
| NORTHERN TRUST CORP | $18.762.609 | 1.006.038 | 0,66% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $18.138.990 | 972.600 | 0,64% | Alım opsiyonu |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $18.004.747 | 965.402 | 0,63% | Hisse senetleri |
| Candriam S.C.A. | $18.002.647 | 966.219 | 0,63% | Hisse senetleri |
| Balyasny Asset Management L.P. | $15.760.873 | 845.087 | 0,55% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $15.685.750 | 841.059 | 0,55% | Hisse senetleri |
| MORGAN STANLEY | $14.928.673 | 800.465 | 0,53% | Hisse senetleri |
| Nuveen, LLC | $14.270.533 | 765.176 | 0,50% | Hisse senetleri |
| Burkehill Global Management, LP | $13.521.250 | 725.000 | 0,48% | Hisse senetleri |
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| New Enterprise Associates 16, L.P., NEA Partners 16, L.P., NEA 16 GP, LLC, NEA 18 Venture Growth Equity, L.P., NEA Partners 18 VGE, L.P., NEA 18 VGE GP, LLC, Forest Baskett, Ali Behbahani, Carmen Chang, Anthony A. Florence, Jr., Mohamad H. Makhzoumi, Scott D. Sandell, Paul Walker ×10 başvurular | 07 Mayıs 2026 | 10,50% | Değişiklik | Pasif yatırım | SEC |
| Omega Fund V, L.P., Omega Fund V GP, L.P., Omega Fund V GP Manager, Ltd., Richard J. Lim, Claudio Nessi, Anne-Mari Paster, Otello Stampacchia | 20 Mayıs 2019 | · | İlk başvuru | Yönetim kurulu kampanyası | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Şirket yöneticileri 37 içeriden öğrenenler · 13 yöneticiler · 9 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Jennifer L Good | President & CEO | 19 Şubat 2026 A | 213.313 | 0 | 0 | $0 |
| David C Hastings | Chief Financial Officer | 08 Ocak 2026 A | · | 0 | 0 | $0 |
| Lisa Delfini | Chief Financial Officer | 31 Mayıs 2025 A | 64.660 | 0 | 0 | $0 |
| Christopher Seiter | Chief Financial Officer | 17 Şubat 2021 A | · | 0 | 0 | $0 |
| Farrell Simon | Chief Commercial Officer | 19 Şubat 2026 A | 76.900 | 0 | 0 | $0 |
| Christopher Galletta | Controller and Principal Accounting Officer | 19 Şubat 2026 A | 26.095 | 0 | 0 | $0 |
| James V Cassella | Chief Development Officer | 19 Şubat 2026 A | · | 0 | 0 | $0 |
| Thomas Sciascia | Chief Scientific Officer | 19 Şubat 2026 A | 221.373 | 0 | 0 | $0 |
| David J Clark | Chief Medical Officer | 15 Şubat 2024 A | · | 0 | 0 | $0 |
| William P Forbes | Chief Development Officer | 29 Haziran 2022 A | · | 0 | 0 | $0 |
| Frank P Muscolo | Controller | 17 Şubat 2021 A | · | 0 | 0 | $0 |
| Helena Brett-Smith | Chief Development Officer | 13 Şubat 2020 A | · | 0 | 0 | $0 |
| Yann Mazabraud | Chief Commercial Officer and Head of International | 13 Şubat 2020 A | · | 0 | 0 | $0 |
| Michael Thomas Heffernan | Yönetim kurulu üyesi | 15 Eylül 2026 M | 6.351 | 0 | 4 | $-595.806 |
| David P Meeker | Yönetim kurulu üyesi | 03 Haziran 2026 A | 352.489 | 0 | 0 | $0 |
| Edward T. Mathers | Yönetim kurulu üyesi | 03 Haziran 2026 A | 948.948 | 0 | 0 | $0 |
| Dominick Colangelo | Yönetim kurulu üyesi | 03 Haziran 2026 A | · | 0 | 0 | $0 |
| Anne Vanlent | Yönetim kurulu üyesi | 03 Haziran 2026 A | 25.983 | 0 | 0 | $0 |
| Mette Kirstine Agger | Yönetim kurulu üyesi | 09 Mayıs 2019 C | 1.151.544 | 0 | 0 | $0 |
| Anna Guyer Mitsak | Yönetim kurulu üyesi | 07 Mayıs 2019 A | · | 0 | 0 | $0 |
| Eran Nadav | Yönetim kurulu üyesi | 07 Mayıs 2019 A | · | 0 | 0 | $0 |
| Mohamad Makhzoumi | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Ali Behbahani | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Anthony A. Florence, Jr. | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Peter W. Sonsini | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Paul Walker | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Forest Baskett | 10% sahip | 11 Nisan 2022 P | 10.421.428 | 0 | 0 | $0 |
| Scott D. Sandell | 10% sahip | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
| Joshua Makower | 10% sahip | 03 Nisan 2020 X | 5.937.998 | 0 | 0 | $0 |
| Debra A Drake | 10% sahip | 09 Mayıs 2019 C | 10.399 | 0 | 0 | $0 |
| Richard King Mellon Foundation | 10% sahip | 09 Mayıs 2019 C | 347.157 | 0 | 0 | $0 |
| Lundbeckfond Invest A/S | 10% sahip | 09 Mayıs 2019 C | 1.151.544 | 0 | 0 | $0 |
| Peter F Drake | 10% sahip | 09 Mayıs 2019 C | 62.540 | 0 | 0 | $0 |
| William J Oshea | 10% sahip | 09 Mayıs 2019 C | 114.080 | 0 | 0 | $0 |
| David M Mott | 10% sahip | 09 Mayıs 2019 C | 4.438.562 | 0 | 0 | $0 |
| Peter J Barris | 10% sahip | 09 Mayıs 2019 C | 4.438.562 | 0 | 0 | $0 |
| Carmen Chang | · | 11 Nisan 2022 P | 948.948 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
ETF sahipliği 23 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PILL · Direxion Shares ETF Trust | 1,55% | 17.529 NS | 31 Temmuz 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 436.183 SH | 11 Eylül 2026 | Günlük |
| VFMO · VANGUARD WELLINGTON FUND | 0,14% | 148.479 SH | 19 Ağustos 2026 | Günlük |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,13% | 10.058 SH | 02 Ekim 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,12% | 114.901 SH | 19 Ağustos 2026 | Günlük |
| IWO · iShares Trust | 0,11% | 1.007.147 SH | 11 Eylül 2026 | Günlük |
| IBB · iShares Trust | 0,11% | 707.885 SH | 11 Eylül 2026 | Günlük |
| RSSL · Global X Funds | 0,06% | 51.308 NS | 31 Temmuz 2026 | N-PORT |
| ISCG · iShares Trust | 0,06% | 37.734 SH | 11 Eylül 2026 | Günlük |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 616.796 SH | 19 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,06% | 2.737.721 SH | 11 Eylül 2026 | Günlük |
| ESML · iShares Trust | 0,05% | 81.532 SH | 11 Eylül 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 287.822 SH | 19 Ağustos 2026 | Günlük |
| FHLC · FIDELITY COVINGTON TRUST | 0,03% | 45.551 NS | 31 Temmuz 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.352.952 SH | 19 Ağustos 2026 | Günlük |
| WSML · iShares Trust | 0,01% | 5.214 SH | 11 Eylül 2026 | Günlük |
| TILT · FlexShares Trust | 0,00% | 3.318 NS | 31 Temmuz 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 152.436 SH | 11 Eylül 2026 | Günlük |
| IWV · iShares Trust | 0,00% | 24.754 SH | 09 Eylül 2026 | Günlük |
| PTH · Invesco Exchange-Traded Fund Trust | 0,00% | 25 SH | 02 Ekim 2026 | Günlük |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.048.595 SH | 19 Ağustos 2026 | Günlük |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 8.874 SH | 19 Ağustos 2026 | Günlük |
| ISCB · iShares Trust | · | 5.335 SH | 11 Eylül 2026 | Günlük |
TRVI Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
derecelendirme · 18 analist
AL
Medyan hedef
$25.00
+79,7%
6 33,3%
Güçlü Al
11 61,1%
Al
1 5,6%
Tut
0 0,0%
Sat
0 0,0%
Güçlü Sat
12 Aylık Fiyat Hedefi
11 analist · 2026-10-04Ortalama hedef $28.18 +102,6%
← Tüm hedeflerin altında
Mevcut fiyat $13.91
Düşük$23.00
Ortalama$28.18
Yüksek$40.00
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
Mali yıl bazında, fiyatlar her şirketin son mali yıl kapanışına göredir.
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| TRVI | $1.61B | -39.1 | · | · | -22.4% | · |
| HRMY | $2.16B | 13.8 | 21.5% | 18.3% | 19.3% | 77.2% |
| PBH | $3.33B | 15.2 | -4.3% | 17.5% | 10.2% | 54.7% |
| GPCR | $14.78B | -86.9 | · | · | -12.3% | · |
| TRLV | · | · | -0.45% | -10.3% | -10.4% | 60.2% |
| NUVB | $3.03B | -14.9 | 699.0% | -325.3% | -60.3% | · |
| SEPN | $1.25B | -25.3 | 4174.5% | -106.4% | -12.9% | · |
| ANIP | $1.78B | 23.8 | 43.8% | 8.9% | 16.6% | · |
| ETON | $457M | · | 104.9% | -5.8% | -18.4% | 53.5% |
| RAPP | $1.45B | -10.6 | · | · | -29.8% | · |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — Yukarıdaki Tam Temeller bölümündeki herhangi bir satırın yanındaki + işaretine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kaynak: SEC 10-Q dosyalandı Ağu 6, 2026